ALR-27, identified by its CAS number 903639-13-4, is a synthetic compound that has garnered interest in the field of medicinal chemistry. While specific details about its characteristics may vary, compounds like ALR-27 typically exhibit properties such as a defined molecular structure, which may include functional groups that influence its reactivity and biological activity. It is often studied for its potential therapeutic applications, particularly in areas such as metabolic disorders or neurodegenerative diseases. The compound's solubility, stability, and interaction with biological targets are crucial for understanding its efficacy and safety profile. Additionally, ALR-27 may undergo various forms of characterization, including spectroscopic analysis and biological assays, to elucidate its mechanism of action and pharmacokinetics. As research progresses, further insights into its properties and applications are likely to emerge, contributing to the broader understanding of its role in drug development.

ALR-27

903639-13-4: ALR-27, identified by its CAS number 903639-13-4, is a synthetic compound that has garnered interest in the field of medicinal chemistry. While specific details about its characteristics may vary, compounds like ALR-27 typically exhibit properties such as a defined molecular structure, which may include functional groups that influence its reactivity and biological activity. It is often studied for its potential therapeutic applications, particularly in areas such as metabolic disorders or neurodegenerative diseases. The compound's solubility, stability, and interaction with biological targets are crucial for understanding its efficacy and safety profile. Additionally, ALR-27 may undergo various forms of characterization, including spectroscopic analysis and biological assays, to elucidate its mechanism of action and pharmacokinetics. As research progresses, further insights into its properties and applications are likely to emerge, contributing to the broader understanding of its role in drug development.

<p>ALR-27 serves as an antagonist of the 5-lipoxygenase (5-LOX) activating protein FLAP and exhibits anti-inflammatory properties. It effectively inhibits 5-LOX product formation (&gt;80%) in pro-inflammatory M1-MDM without significantly inhibiting 5-LOX directly. Additionally, ALR-27 decreases prostaglandin and leukotriene (LT) production in neutrophils and enhances the production of specialized prolytic mediators in certain human macrophage phenotypes [1].</p>

CAS 903639-13-4

ALR-27

ALR-27

Ref: TM-T85637